Interstitial Glucose and Physical Exercise in Type 1 Diabetes: Integrative Physiology, Technology, and the Gap In-Between
- PMID: 29342932
- PMCID: PMC5793321
- DOI: 10.3390/nu10010093
Interstitial Glucose and Physical Exercise in Type 1 Diabetes: Integrative Physiology, Technology, and the Gap In-Between
Abstract
Continuous and flash glucose monitoring systems measure interstitial fluid glucose concentrations within a body compartment that is dramatically altered by posture and is responsive to the physiological and metabolic changes that enable exercise performance in individuals with type 1 diabetes. Body fluid redistribution within the interstitial compartment, alterations in interstitial fluid volume, changes in rate and direction of fluid flow between the vasculature, interstitium and lymphatics, as well as alterations in the rate of glucose production and uptake by exercising tissues, make for caution when interpreting device read-outs in a rapidly changing internal environment during acute exercise. We present an understanding of the physiological and metabolic changes taking place with acute exercise and detail the blood and interstitial glucose responses with different forms of exercise, namely sustained endurance, high-intensity, and strength exercises in individuals with type 1 diabetes. Further, we detail novel technical information on currently available patient devices. As more health services and insurance companies advocate their use, understanding continuous and flash glucose monitoring for its strengths and limitations may offer more confidence for patients aiming to manage glycemia around exercise.
Keywords: continuous glucose monitoring; exercise; flash glucose monitoring; interstitium.
Conflict of interest statement
O.M. has received lecture fees from Medtronic (Medtronic MiniMed, Inc., Northridge, CA, USA), travel fees from Novo Nordisk A/S and received a grant from Sêr Cymru II COFUND fellowship/European Union. No conflict of interest for J.E.Y. R.M.B. reports having received honoraria, travel, and educational grant support from Boehringer-Ingelheim (Ingelheim am Rhein, Germany), Eli Lily and Company (Indianapolis, IN, USA), Novo Nordisk (Bagsværd, Denmark), and Sanofi-Aventis (Paris, France).
References
-
- The Health and Social Care Information Centre National Diabetes Audit 2012–2013, Report 2. [(accessed on 27 November 2017)]; Available online: http://content.digital.nhs.uk/catalogue/PUB16496/nati-diab-audi-12-13-re....
-
- Dorman J.S., Laporte R.E., Kuller L.H., Cruickshanks K.J., Orchard T.J., Wagener D.K., Becker D.J., Cavender D.E., Drash A.L. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study: Mortality results. Diabetes. 1984;33:271–276. doi: 10.2337/diab.33.3.271. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
